Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,439,129
+$351,897 QoQ
Shares Held
5,719
+14.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,214
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WATERS PARKERSON & CO., LLC holds $91,644,016 across 10 Drug Manufacturers - General names. ABBV ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
344,962 | $44,327,617 | |
| 2 | JNJ |
Johnson & Johnson
|
109,533 | $27,818,096 | |
| 3 | LLY |
ELI LILLY & Co
|
10,667 | $12,794,320 | |
| 4 | PFE |
Pfizer Inc
|
96,842 | $2,331,955 | |
| 5 | AMGN |
Amgen Inc
|
4,137 | $1,498,090 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
5,719 | $1,439,129 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,037 | $693,571 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,152 | $271,883 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,439,129 | 5,719 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,087,232 | 4,999 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,147,933 | 5,024 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,167,193 | 5,041 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $935,710 | 5,041 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,056,190 | 5,041 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,066,555 | 6,002 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,360,834 | 6,891 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,181,944 | 6,891 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,276,521 | 7,010 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,090,678 | 7,038 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $986,628 | 6,619 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $927,077 | 6,881 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,096,624 | 6,881 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,188,803 | 7,356 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $906,722 | 6,756 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,034,748 | 6,756 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,062,793 | 6,556 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $870,351 | 6,428 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $693,388 | 6,428 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $724,049 | 6,428 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $695,638 | 6,428 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $742,335 | 6,928 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $520,372 | 5,941 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $579,654 | 5,904 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $449,825 | 5,904 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||